N. Zabaleta
发表
G. González-Aseguinolaza,
R. Aldabe,
N. Weber,
2021,
JHEP reports : innovation in hepatology.
James M. Wilson,
G. Ronzitti,
L. Vandenberghe,
2022,
Molecular Therapy.
Brian L. Price,
Elissa M. Hudspeth,
M. Freeman,
2021,
bioRxiv.
L. Vandenberghe,
Dawid Maciorowski,
N. Zabaleta,
2022,
Viruses.
H. Petry,
Valérie Ferreira,
S. V. van Deventer,
2019,
Blood advances.
H. Petry,
Valérie Ferreira,
G. González-Aseguinolaza,
2017,
Molecular therapy : the journal of the American Society of Gene Therapy.
J. Segovia,
J. Bueren,
G. González-Aseguinolaza,
2020,
bioRxiv.
G. González-Aseguinolaza,
N. Weber,
N. Zabaleta,
2022,
Hepatology.
A. Wagers,
Erin Merkel,
L. Vandenberghe,
2022,
Cell reports. Medicine.
C. Solano,
I. Lasa,
G. González-Aseguinolaza,
2020,
The Journal of Immunology.
G. González-Aseguinolaza,
C. Unzu,
N. Weber,
2023,
Nature Reviews Gastroenterology & Hepatology.
J. Carette,
L. Vandenberghe,
Sirika Pillay,
2019,
Molecular therapy : the journal of the American Society of Gene Therapy.
J. Ruiz-Ederra,
P. de la Villa,
A. Anasagasti,
2020,
Pharmaceutics.
Gregory A. Newby,
J. Seidman,
H. Wakimoto,
2023,
Nature Medicine.
G. González-Aseguinolaza,
N. Zabaleta,
M. Hommel,
2019,
Human gene therapy.
J. Prieto,
G. González-Aseguinolaza,
J. Bilbao,
2017,
Human gene therapy. Clinical development.
Elissa M. Hudspeth,
M. Freeman,
M. Betts,
2021,
Cell Host & Microbe.
E. Salido,
F. Prósper,
G. González-Aseguinolaza,
2018,
Nature Communications.
J. Segovia,
J. Bueren,
G. González-Aseguinolaza,
2020,
Molecular therapy. Methods & clinical development.
S. Joshi,
D. Volkin,
L. Vandenberghe,
2023,
bioRxiv.
E. Salido,
F. Prósper,
G. González-Aseguinolaza,
2018,
Nature Communications.
R. Sanders,
M. V. van Gils,
L. Vandenberghe,
2022,
iScience.
S. Joshi,
D. Volkin,
L. Vandenberghe,
2023,
Molecular Therapy - Methods & Clinical Development.
M. Boerries,
A. Abad,
Á. Vales,
2024,
EMBO molecular medicine.
S. Joshi,
D. Volkin,
L. Vandenberghe,
2023,
Molecular Therapy - Methods & Clinical Development.
N. Zabaleta,
Laura Torella,
Nerea Santana-Gonzalez,
2024,
FEBS letters.